Cargando…

IDO-GCN2 and autophagy in inflammation

Detalles Bibliográficos
Autor principal:	McGaha, Tracy L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial: Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673112/ https://www.ncbi.nlm.nih.gov/pubmed/26317232

Ejemplares similares

Myeloid Responses to Extracellular Vesicles in Health and Disease
por: Makhijani, Priya, et al.
Publicado: (2022)

Amino Acid Transport and Metabolism in Myeloid Function
por: Halaby, Marie Jo, et al.
Publicado: (2021)

Impact of IDO1 and IDO2 on the B Cell Immune Response
por: Merlo, Lauren M. F., et al.
Publicado: (2022)

Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses
por: Merlo, Lauren M. F., et al.
Publicado: (2020)

GCN2 controls the cellular checkpoint: potential target for regulating inflammation
por: Xia, Xiaojing, et al.
Publicado: (2018)

Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans
por: Napolioni, Valerio, et al.
Publicado: (2019)

IDO2 in Immunomodulation and Autoimmune Disease
por: Prendergast, George C., et al.
Publicado: (2014)

GCN2 and TOR converge on aging
por: Vlanti, Anna, et al.
Publicado: (2013)

On the Non-Redundant Roles of TDO2 and IDO1
por: Puccetti, Paolo
Publicado: (2014)

Current Challenges for IDO2 as Target in Cancer Immunotherapy
por: Mondanelli, Giada, et al.
Publicado: (2021)

TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE
por: Ehlers, Marc, et al.
Publicado: (2006)

Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner
por: Royzman, Dmytro, et al.
Publicado: (2019)

New Insights into IDO Biology in Bacterial and Viral Infections
por: Schmidt, Susanne V., et al.
Publicado: (2014)

Immunological Relevance of the Coevolution of IDO1 and AHR
por: Jaronen, Merja, et al.
Publicado: (2014)

IDO Targeting in Sarcoma: Biological and Clinical Implications
por: Nafia, Imane, et al.
Publicado: (2020)

IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
por: Huang, Yi-Shu, et al.
Publicado: (2020)

Targeting Tregs in Malignant Brain Cancer: Overcoming IDO
por: Wainwright, Derek A., et al.
Publicado: (2013)

IDO Expression in Cancer: Different Compartment, Different Functionality?
por: Meireson, Annabel, et al.
Publicado: (2020)

Dengue Virus Induced COX-2 Signaling Is Regulated Through Nutrient Sensor GCN2
por: Afroz, Sumbul, et al.
Publicado: (2020)

Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies
por: Zhai, Lijie, et al.
Publicado: (2020)

Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
por: Platten, Michael, et al.
Publicado: (2015)

The Coevolution of IDO1 and AhR in the Emergence of Regulatory T-Cells in Mammals
por: Grohmann, Ursula, et al.
Publicado: (2015)

AhR-Mediated, Non-Genomic Modulation of IDO1 Function
por: Pallotta, Maria Teresa, et al.
Publicado: (2014)

Tolerogenic IDO(+) Dendritic Cells Are Induced by PD-1-Expressing Mast Cells
por: Rodrigues, Cecilia Pessoa, et al.
Publicado: (2016)

Tryptophan Feeding of the IDO1-AhR Axis in Host–Microbial Symbiosis
por: Zelante, Teresa, et al.
Publicado: (2014)

Limitations and Off-Target Effects of Tryptophan-Related IDO Inhibitors in Cancer Treatment
por: Günther, Juliane, et al.
Publicado: (2019)

The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1
por: Panfili, Eleonora, et al.
Publicado: (2023)

Role of Autophagy in Lung Inflammation
por: Painter, Jacob D., et al.
Publicado: (2020)

Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis
por: Lemos, Henrique, et al.
Publicado: (2020)

Risk of Colorectal Polyps and Malignancies Among Predominantly Rural Hispanics
por: Orsak, Gabriela, et al.
Publicado: (2018)

Modulation of immune cell function, IDO expression and kynurenine production by the quorum sensor 2-heptyl-3-hydroxy-4-quinolone (PQS)
por: Ogbechi, Joy, et al.
Publicado: (2022)

Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO
por: Kim, Minah, et al.
Publicado: (2021)

Acetyltransferase GCN5 regulates autophagy and lysosome biogenesis by targeting TFEB
por: Wang, Yusha, et al.
Publicado: (2019)

IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells via Aryl Hydrocarbon Receptor Activation
por: Amobi-McCloud, Adaobi, et al.
Publicado: (2021)

The Interplay between NLRs and Autophagy in Immunity and Inflammation
por: Carneiro, Leticia A. M., et al.
Publicado: (2013)

Tumor-Targeted Gene Silencing IDO Synergizes PTT-Induced Apoptosis and Enhances Anti-tumor Immunity
por: Zhang, Yujuan, et al.
Publicado: (2020)

Dynamic change of IDO1 activity predicts survival in patients with unresectable stage III NSCLC and chemoradiotherapy
por: Wu, Linfang, et al.
Publicado: (2022)

Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer
por: Passarelli, Anna, et al.
Publicado: (2022)

DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota
por: Zhao, Li-Ping, et al.
Publicado: (2023)

Lymphocyte Activation Gene-3 (LAG-3) Negatively Regulates Environmentally-Induced Autoimmunity
por: Jha, Vibha, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i838gkm8p7cpfnq3l20hm5rt15